OptimizeRx (OPRX) Scheduled to Post Earnings on Wednesday

OptimizeRx (NASDAQ:OPRX) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, November 13th. Analysts expect OptimizeRx to post earnings of $0.06 per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

OptimizeRx Trading Down 3.5 %

OptimizeRx stock opened at $6.06 on Tuesday. The firm’s 50-day moving average is $6.81 and its 200-day moving average is $9.12. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.07 and a current ratio of 3.07. OptimizeRx has a 1 year low of $5.04 and a 1 year high of $16.65. The company has a market cap of $111.02 million, a P/E ratio of -6.06 and a beta of 1.32.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on OPRX. B. Riley began coverage on shares of OptimizeRx in a research report on Thursday, July 25th. They issued a “buy” rating and a $18.50 price target on the stock. Barclays reduced their price target on shares of OptimizeRx from $15.00 to $11.00 and set an “equal weight” rating on the stock in a research report on Monday, August 12th. Finally, Royal Bank of Canada cut their price objective on shares of OptimizeRx from $17.00 to $14.00 and set an “outperform” rating on the stock in a research report on Friday, August 16th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $14.50.

OptimizeRx Company Profile

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events.